Literature DB >> 11961394

Role of nitric oxide in inflammatory conditions.

Roland C Blantz1, Karen Munger.   

Abstract

Nitric oxide (NO) plays an important regulatory/modulatory role in a variety of inflammatory conditions. NO is a small, short-lived molecule that is released from a variety of cells in response to homeostatic and pathologic stimuli. It may act as a vasodilator and a platelet inhibitor and may interfere with adhesion molecules to prevent neutrophil adhesion. NO release may also lead to the formation of highly reactive species such as peroxynitrite and stable nitrosothiols and may cause mitochondrial damage and nitration of protein tyrosine residues. In addition, NO inhibits cell proliferation via inhibition of polyamine synthesis and cell uptake and may well act as a 'brake' on the proliferative response following cytokine exposure. All three isoforms of nitric oxide synthases are found in the kidney during inflammation. The site of NO release impacts significantly on its net function and structural impact. NO plays a protective role in many forms of immune injury, such as nephrotoxic serum-induced glomerulonephritis, autoimmune tubular interstitital nephritis, and experimental allergic encephalomyelitis. NO overproduction in sepsis, after cytokine exposure, inducible NO synthase transcription, and local inflammation can autoinhibit endothelial NO synthase, leading to selective renal and mesenteric vasoconstriction. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11961394     DOI: 10.1159/000054723

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  22 in total

1.  Factors influencing protein tyrosine nitration--structure-based predictive models.

Authors:  Alexander S Bayden; Vasily A Yakovlev; Paul R Graves; Ross B Mikkelsen; Glen E Kellogg
Journal:  Free Radic Biol Med       Date:  2010-12-21       Impact factor: 7.376

2.  Reprogrammed fibrocytes induce a mixed Th1/Th2 cytokine response of naïve CD4(+) T cells.

Authors:  Abelardo Medina; Aziz Ghahary
Journal:  Mol Cell Biochem       Date:  2010-10-05       Impact factor: 3.396

Review 3.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

4.  Expression of nitric oxide synthase isoforms in the mouse kidney: cellular localization and influence by lipopolysaccharide and Toll-like receptor 4.

Authors:  Bo Holmqvist; Christina Falk Olsson; Maj-Lis Svensson; Catharina Svanborg; Johan Forsell; Per Alm
Journal:  J Mol Histol       Date:  2006-05-19       Impact factor: 2.611

5.  IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis.

Authors:  Adam I Kaplin; Deepa M Deshpande; Erick Scott; Chitra Krishnan; Jessica S Carmen; Irina Shats; Tara Martinez; Jennifer Drummond; Sonny Dike; Mikhail Pletnikov; Sanjay C Keswani; Timothy H Moran; Carlos A Pardo; Peter A Calabresi; Douglas A Kerr
Journal:  J Clin Invest       Date:  2005-09-22       Impact factor: 14.808

6.  The effect of corticosteroid therapy on cyclooxygenase 2, vascular endothelial growth factor, and inducible nitric oxide synthase expression levels in nasal polyposis.

Authors:  Demet Yazici; Ülkü Tuncer; Aysun Uğuz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06       Impact factor: 2.503

7.  NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease.

Authors:  Devram Sampat Ghorpade; Akhuri Yash Sinha; Sahana Holla; Vikas Singh; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2013-10-03       Impact factor: 5.157

8.  Suppressive Effect on Lipopolysaccharide-Induced Proinflammatory Mediators by Citrus aurantium L. in Macrophage RAW 264.7 Cells via NF-κB Signal Pathway.

Authors:  Sang-Rim Kang; Dae-Yong Han; Kwang-Il Park; Hyeon-Soo Park; Yong-Bae Cho; Hu-Jang Lee; Won-Sup Lee; Chung Ho Ryu; Yeong Lae Ha; Do Hoon Lee; Jin A Kim; Gon-Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-21       Impact factor: 2.629

9.  Nitric oxide inhibits glomerular TGF-beta signaling via SMOC-1.

Authors:  Ellen Dreieicher; Karl-Friedrich Beck; Sandra Lazaroski; Meike Boosen; Wasiliki Tsalastra-Greul; Martina Beck; Ingrid Fleming; Liliana Schaefer; Josef Pfeilschifter
Journal:  J Am Soc Nephrol       Date:  2009-07-02       Impact factor: 10.121

Review 10.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.